Moreover, ALK rearrangements have been identified in ALCL (translocation, 60%) (Falini et al., 1998), thyroid cancer (translocation, 2.2%) (Chou et al., 2015), and neuroblastoma (point mutation, 10.5%) (Rosswog et al., 2023), among others. Here, ALK is linked to neuroblastoma.